One messenger, Li Xilu, is reading her letter to Zhong Nanshan, Director of State Key Laboratory of Respiratory Disease, and the leader of the medical team fighting against Severe Acute Respiratory Syndromes (SARS) outbreak in China twelve years ago. [Photo provided to Newsgd.com]
In fact, Guangzhou Phar. Holdings has achieved substantial progress in invigorating the brand.
Vinorelbine Tartrate, an anti-tumor medicine developed by the company, was granted the certificate of suitability to monograph by the European Pharmacopeia (CEP) in June this year. The certificate is one of the drug certifications that has the highest threshold to entry worldwide, and having been awarded this certification, it will allow the medicine to enter the European market.
“Chinese medicine is a vital component of Guangzhou’s culture,” said Li Chuyuan, Chairman of the Guangzhou Phar. Holdings, “and the Fortune Global Forum provides a precious opportunity to bring Guangzhou to the world stage. We will give full support to the forum and help promote Guangzhou and its unique culture.”
Guangzhou Phar. Holding will help organize a sub-forum during the upcoming 2017 Fortune Global Forum. With the theme of “The Future of Healthcare”, the sub-forum will be a significant platform to showcase Guangzhou and its bio-medicine industry.